DK0893992T3 - Hurtigt sönderdelende oral doseringsform - Google Patents

Hurtigt sönderdelende oral doseringsform

Info

Publication number
DK0893992T3
DK0893992T3 DK97918112T DK97918112T DK0893992T3 DK 0893992 T3 DK0893992 T3 DK 0893992T3 DK 97918112 T DK97918112 T DK 97918112T DK 97918112 T DK97918112 T DK 97918112T DK 0893992 T3 DK0893992 T3 DK 0893992T3
Authority
DK
Denmark
Prior art keywords
dosage form
pct
date oct
oral dosage
sec
Prior art date
Application number
DK97918112T
Other languages
Danish (da)
English (en)
Inventor
Pierre Humbert-Droz
Matthias Seidel
Rosa Martani
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Application granted granted Critical
Publication of DK0893992T3 publication Critical patent/DK0893992T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97918112T 1996-04-16 1997-04-04 Hurtigt sönderdelende oral doseringsform DK0893992T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810236 1996-04-16
PCT/EP1997/001696 WO1997038679A2 (fr) 1996-04-16 1997-04-04 Forme galenique orale se desintegrant rapidement

Publications (1)

Publication Number Publication Date
DK0893992T3 true DK0893992T3 (da) 2004-06-01

Family

ID=8225590

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97918112T DK0893992T3 (da) 1996-04-16 1997-04-04 Hurtigt sönderdelende oral doseringsform

Country Status (13)

Country Link
US (1) US6083531A (fr)
EP (1) EP0893992B1 (fr)
JP (1) JP2000508649A (fr)
AT (1) ATE260646T1 (fr)
AU (1) AU2636797A (fr)
DE (1) DE69727922T2 (fr)
DK (1) DK0893992T3 (fr)
ES (1) ES2217410T3 (fr)
HK (1) HK1016492A1 (fr)
PT (1) PT893992E (fr)
TR (1) TR199802068T2 (fr)
WO (1) WO1997038679A2 (fr)
ZA (1) ZA973190B (fr)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010041609A (ko) * 1998-03-06 2001-05-25 유란드 인터내셔날 에스.피.아. 속해성 정제
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
ID29270A (id) * 1998-11-20 2001-08-16 Rtp Pharma Inc Partikel-partikel mikro yang distabilkan oleh fosfolipid yang dapat menyebar
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
AU765526B2 (en) * 1999-08-17 2003-09-18 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
PL203804B1 (pl) * 2000-06-27 2009-11-30 Hoffmann La Roche Sposób wytwarzania kompozycji farmaceutycznej w postaci spoistej, płytkowej, piankowej, gąbczastej lub ciastowatej struktury i kompozycja farmaceutyczna otrzymana tym sposobem
US6733781B2 (en) 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
US7799342B2 (en) 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
IN192750B (fr) * 2000-12-15 2004-05-15 Ranbaxy Lab Ltd
US6544557B2 (en) 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
FR2833173B1 (fr) * 2001-12-10 2004-08-27 Roquette Freres Preparation antipyretique renfermant du xylitol
US20030148818A1 (en) * 2002-01-18 2003-08-07 Myrhum Mark C. Golf club woods with wood club head having a selectable center of gravity and a selectable shaft
CN100556762C (zh) * 2002-02-13 2009-11-04 迈克尔K·韦伯尔 药物剂型及其制造方法
US8741348B2 (en) 2002-12-20 2014-06-03 Niconovum Ab Physically and chemically stable nicotine-containing particulate material
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
AU2004273618B2 (en) * 2003-09-24 2008-03-13 Novartis Consumer Health S.A. Coated tablets
US20050196441A1 (en) * 2003-11-05 2005-09-08 Dvorsky James E. Quick dissolving agrochemical and animal health products
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
EP1691631A4 (fr) 2003-11-07 2012-09-05 Us Smokeless Tobacco Co Compositions a base de tabac
JP5154924B2 (ja) 2004-05-11 2013-02-27 エガレット エイ／エス ジェランガムを含む膨張可能な投与形態
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
US7992575B2 (en) * 2005-02-28 2011-08-09 U.S. Smokeless Tobacco Company Use of chlorate, sulfur or ozone to reduce tobacco specific nitrosamines
IS7724A (is) 2005-03-02 2006-09-03 Actavis Group Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
JO3352B1 (ar) * 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
GB0516604D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Rapidly dispersing/disintegrating compositions
KR100702069B1 (ko) 2005-10-31 2007-03-30 (주)이엘티사이언스 파라세타몰 경구용 수용산제 복합조성물 및 그 제조방법
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
JP5694645B2 (ja) 2006-03-16 2015-04-01 ニコノヴァム エービーＮｉｃｏｎｏｖｕｍ Ａｂ 改善された嗅ぎたばこ組成物
WO2008079343A2 (fr) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Comprimés à désintégration par voie orale contenant une dose élevée de principes actifs: composition utilisée et méthodes de fabrication
ES2302650B1 (es) 2007-01-11 2009-02-16 Tedec-Meiji Farma, S.A. Composicion de rapida desintegracion en la cavidad bucal.
GB0709541D0 (en) * 2007-05-17 2007-06-27 Jagotec Ag Pharmaceutical excipient
US9271524B1 (en) 2007-09-07 2016-03-01 U.S. Smokeless Tobacco Company Tobacco having reduced tobacco specific nitrosamine content
EP2217213B1 (fr) 2007-10-31 2017-05-24 Johnson & Johnson Consumer Inc. Forme posologique se désintégrant dans la bouche
CA2716901C (fr) * 2008-02-28 2018-07-03 R.P. Scherer Technologies, Llc Procede visant a reduire le polymorphisme
EP2133071A1 (fr) * 2008-06-09 2009-12-16 Université de la Méditerranée Procédé pour fabriquer des formes de dosage de rétention gastrique
FR2933959B1 (fr) * 2008-07-16 2010-09-10 Roquette Freres Procede de fabrication de films directement en alveole.
IT1393331B1 (it) * 2009-02-09 2012-04-20 Graal S R L Composizioni orosolubili e/o effervescenti contenenti almeno un sale di s-adenosilmetionina (same)
CN101919805B (zh) 2009-04-22 2014-01-29 苏维拉克博士皮肤治疗方案股份公司 包含抗坏血酸磷酸酯镁盐的冻干模塑制品
AU2010262738A1 (en) * 2009-05-20 2011-10-13 Lingual Consegna Pty Ltd Buccal and/or sublingual therapeutic formulation
WO2011026080A1 (fr) 2009-08-31 2011-03-03 Wilmington Pharmaceuticals, Llc Compositions à désintégration rapide de méloxicame, procédés pour sa fabrication et utilisation pour traiter l'arthrite et/ou la douleur
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US8343533B2 (en) 2009-09-24 2013-01-01 Mcneil-Ppc, Inc. Manufacture of lozenge product with radiofrequency
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
MX343047B (es) * 2010-09-22 2016-10-21 Mcneil-Ppc Inc Fabricacion de formas de dosificacion de densidad variable con el uso de energia de radiofrecuencia.
WO2012039790A1 (fr) * 2010-09-22 2012-03-29 Mcneil-Ppc, Inc. Fabrication de comprimés à partir d'un mélange pulvérulent auquel de l'énergie est appliquée
WO2012039789A1 (fr) * 2010-09-22 2012-03-29 Mcneil-Ppc, Inc. Fabrication de formes pharmaceutiques à densité variable utilisant l'énergie de radiofréquence
US8545902B2 (en) 2010-12-15 2013-10-01 Nicholas Lion Dosage forms of plant-derived cathartics
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
WO2014007779A1 (fr) 2012-07-06 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Formulations de dexkétoprofène à désintégration orale
WO2014007780A1 (fr) 2012-07-06 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Formulations de dexkétoprofène à désintégration orale
US20140255452A1 (en) 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
MX368159B (es) 2014-01-10 2019-09-20 Johnson & Johnson Consumer Inc Proceso para elaborar tabletas con el uso de radiofrecuencia y partículas disipativas revestidas.
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
EP3807260A1 (fr) 2018-06-15 2021-04-21 R. J. Reynolds Tobacco Company Purification de nicotine
KR20230098236A (ko) * 2020-10-30 2023-07-03 디에스엠 아이피 어셋츠 비.브이. Hmo를 포함하는 비-발포성 용해가능한 정제

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2887437A (en) * 1956-08-22 1959-05-19 Pfizer & Co C Palatable vitamin tablet containing an amino acid
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5219574A (en) * 1989-09-15 1993-06-15 Cima Labs. Inc. Magnesium carbonate and oil tableting aid and flavoring additive
WO1991004018A1 (fr) * 1989-09-15 1991-04-04 Cima Labs, Inc. Materiau a magnesie carbonatee et a huile destine a faciliter la fabrication des comprimes
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
WO1991004757A1 (fr) * 1989-10-02 1991-04-18 Cima Labs, Inc. Presentation sous forme effervescente d'un medicament a usage pediatrique
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
HU219349B (en) * 1991-12-24 2001-03-28 Yamanouchi Pharma Co Ltd Intrabuccally disintegrating preparation and production thereof
KR100286505B1 (ko) * 1992-02-18 2001-04-16 니뽄 신야쿠 가부시키가이샤 속용정
US5330760A (en) * 1992-08-27 1994-07-19 Sterling Winthrop Inc. Effervescent antacid
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
EP0743850B1 (fr) * 1994-01-27 1999-10-06 The Board Of Regents Of The University Of Oklahoma Forme de dosage orale a dissolution rapide
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)

Also Published As

Publication number Publication date
ZA973190B (en) 1997-12-17
ATE260646T1 (de) 2004-03-15
PT893992E (pt) 2004-06-30
HK1016492A1 (en) 1999-11-05
EP0893992A2 (fr) 1999-02-03
WO1997038679A2 (fr) 1997-10-23
WO1997038679A3 (fr) 1997-12-04
DE69727922T2 (de) 2005-01-20
DE69727922D1 (de) 2004-04-08
AU2636797A (en) 1997-11-07
US6083531A (en) 2000-07-04
TR199802068T2 (xx) 2000-01-21
JP2000508649A (ja) 2000-07-11
ES2217410T3 (es) 2004-11-01
EP0893992B1 (fr) 2004-03-03

Similar Documents

Publication Publication Date Title
DK0893992T3 (da) Hurtigt sönderdelende oral doseringsform
HU9603228D0 (en) Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
AU1537095A (en) Therapeutic agents containing thyroid hormones
ATE293458T1 (de) Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
TR199802698T2 (xx) Valsartan�n kat� oral doz formlar�.
RU2220723C2 (ru) Средство и способ лечения или профилактики артериосклероза
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
BR9910180A (pt) Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
IL133397A0 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
IL108234A0 (en) Pharmaceutical composition containing galanthamine
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
PL348202A1 (en) Pharmaceutically active composition and dispensing device
SE9501881D0 (sv) New pharmacological use of AII-receptor antagonists
EE03385B1 (et) Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid
GR3030954T3 (en) Children-proof package for active substance-containing plaster
GEP20043377B (en) Pharmaceutical Complex
ATE288756T1 (de) Verwendung von nk-1 rezeptorantagonisten zur behandlung von schweren depressionen, die von angstzuständen begleitet werden
SE9700868D0 (sv) Kalciumkomposition
MY127600A (en) Solid oral dosage forms of valsartan